Depleting hsa_circ_0000567 suppresses acquired gefitinib resistance and proliferation of lung adenocarcinoma cells through regulating the miR-377-3p / ZFX axis: an in vitro and in vivo study.
Lists
Only you see this
Abstract
The hsa_circ_0000567/miR-377-3p/ZFX axis might contribute to acquired gefitinib resistance in LUAD cells both in vitro and in vivo, suggesting hsa_circ_0000567 as a novel therapeutic target in treatment of gefitinib-resistant LUAD.
BibTeX
@inproceedings{wang2022depleting,
author = {Lanjun Wang and Mengqi Li and Rong Lian},
title = {{Depleting hsa\_circ\_0000567 suppresses acquired gefitinib resistance and proliferation of lung adenocarcinoma cells through regulating the miR-377-3p / ZFX axis: an in vitro and in vivo study.}},
booktitle = {PubMed},
year = {2022},
doi = {10.14670/hh-18-431},
}Loading related content...